0001562180-24-004462.txt : 20240528 0001562180-24-004462.hdr.sgml : 20240528 20240528162248 ACCESSION NUMBER: 0001562180-24-004462 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240525 FILED AS OF DATE: 20240528 DATE AS OF CHANGE: 20240528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Elston George CENTRAL INDEX KEY: 0001429932 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 24992165 MAIL ADDRESS: STREET 1: 124 CHATHAM STREET CITY: CHATHAM STATE: NJ ZIP: 07928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-05-25 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001429932 Elston George C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 false true false false Chief Financial Officer false Common Stock 2024-05-25 4 M false 7500.00 0.00 A 51107.00 D Common Stock 2024-05-25 4 F false 3627.00 11.16 D 47480.00 D Restricted Stock Units 0.00 2024-05-25 4 M false 7500.00 0.00 D Common Stock 7500.00 15000.00 D No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units. The restricted stock units vest in three ratable annual installments beginning May 25, 2024. /s/ Ron Honig, Attorney-in-Fact 2024-05-28